Proteome Systems and Iberica to Collaborate on Osteoarthritis

Proteome Systems of Sydney and Iberica, a Japanese clinical research consulting firm, said last week that they were going to collaborate to analyze proteoglycan changes associated with the progression and treatment of osteoarthritis.

The project is part of an ongoing collaboration between the Iberica-Kurume Translational Research Center in Kurume, Japan, and the department of orthopaedics at Kurume University to find biomarkers for the diagnosis and treatment of osteoarthritis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.